publication venue for Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing-Remitting Multiple Sclerosis: STRIVE Data Analysis.. 12. 2023 An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert Opinion.. 8. 2019